The incidence of cancer associated with the treatment of rheumatoid arthritis

Seminars in Arthritis and Rheumatism

Volumn 29, Issue 3, 1999, Pages 148-158

  Beauparlant, Pierre ^a   Papp, Kim ^b   Haraoui, Boulos ^c,d  

^a Novartis PharmaceuticalsCanada   (Canada)

^b PROBITY MEDICAL RESEARCH   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d Campus Notre Dame   (Canada)

Author keywords

Antirheumatic drugs; Immunosuppression; Malignancy; Rheumatoid arthritis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GOLD; METHOTREXATE;

ARTICLE; BLADDER CANCER; CANCER INCIDENCE; CANCER RISK; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LYMPHOMA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0033385944     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-0172(99)80026-2     Document Type: Article

References (103)

1. Tugwell P. Pincus T. Yocum D. Stein M. Gluck O. Kraag G. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group N Engl J Med 333 1995 137 141
2. Jacobson D.L. Gange S.J. Rose N.R. Graham N.M.H. Epidemiology and estimated population burden of selected autoimmune disease in the United States Clin Immunol Immunopathol 84 1997 223 243
3. Cobb S. Anderson F. Bauer W. Length of life and cause of death in rheumatoid arthritis N Engl J Med 249 1953 553 556
4. Berntsen C.A. Freyberg R.H. Rheumatoid arthritis patients after five or more years of corticosteroid treatment: A comparative analysis of 183 cases Ann Intern Med 54 1961 938 942
5. Reah T.G. The prognosis of rheumatoid arthritis Proc R Soc Med 56 1963 813 820
6. Oleinick A. Leukemia or lymphoma occurring subsequent to an autoimmune disease Blood 29 1967 144 153
7. Owen D.S. Waller M. Toone E. Rheumatoid disease and malignancy Arthritis Rheum 10 1967 302 303
8. Miller D.G. The association of immune disease and malignant lymphoma Ann Intern Med 66 1967 507 521
9. Mutru O. Laakso M. Isomaki H. Koota K. Ten year mortality and causes of death in patients with rheumatoid arthritis Br J Med 290 1985 1797 1799
10. Monson R.R. Hall A.P. Mortality among arthritics J Chron Dis 29 1976 459 467
11. Lewis P. Hazleman B.L. Hanna R. Roberts S. Causes of death in patients with rheumatoid arthritis with particular reference to azathioprine Ann Rheum Dis 39 1980 457 461
12. Isomi H.A. Mutro O. Koota K. Death rate and causes of death in patients with rheumatoid arthritis Scand J Rheumatol 4 1975 205 208
13. Rasker J.J. Cosh J.A. Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis Ann Rheum Dis 40 1981 115 120
14. Allenbeck P. Increased mortality in rheumatoid arthritis: The use of a medical information system for assessment of death risks Scand J Rheumatol 11 1982 81 86
15. Vandenbroucke J.P. Hazevoet H.M. Cats A. Survival and cause of death in rheumatoid arthritis: a 25 year prospective follow-up J Rheumatol 11 1984 158 161
16. Prior P. Symmons D.P.M. Scott D.L. Brown R. Hawkins C.F. Cause of death in rheumatoid arthritis Br J Rheumatol 23 1984 92 99
17. Wolfe F. Mitchell D.M. Sibley J.T. Fries J.F. Bloch D.A. Williams C.A. The mortality of rheumatoid arthritis Arthritis Rheum 37 1994 481 494
18. Reilly P.A. Cosh J.A. Maddison P.J. Rasker J.J. Silman A.J. Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients Ann Rheum Dis 49 1990 363 369
19. Jacobsson L.T.H. Knowler W.C. Pillemer S. Hanson R.L. Pettitt D.J. Nelson R.G. Rheumatoid arthritis and mortality: a longitudinal study in Pima indians Arthritis Rheum 36 1993 1045 1053
20. Jan 1 Pincus T. Brooks R.H. Callahan L.E. Prediction of longterm mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures Ann Intern Med 120 1 1994 26 34
21. Linos A. Worthington J.W. O'Fallon W.M. Kurland L.T. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of its incidence, prevalence and mortality Am J Epidemiol 111 1980 87 98
22. Isomäcki H.A. Hakulinen T. Joutsenlathi U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis J Chron Dis 31 1978 691 696
23. Macfarlane G.L. Black R.J. Rheumatoid arthritis and lymphatic cancer Eur J Cancer 32 1996 1630 1632
24. Isomäki H.A. Hakulinen T. Joutsenlahti U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis Ann Rheum Dis 41 1982 34 36
25. [letter] Kauppi M. Pukkala E. Isomaki H. Excess risk of lung cancer in patients with rheumatoid arthritis J Rheumatol 23 1996 1484 1485
26. Kauppi M. Pukkala E. Isomaki H. Low incidence of colorectal cancer in patients with rheumatoid arthritis Clin Exp Rheumatol 14 1996 551 553
27. Gridley G. McLaughlin J.K. Ekbom A. Klareskog L. Adami H.-O. Hacker D.G. Incidence of cancer among patients with rheumatoid arthritis J Natl Cancer Inst 85 1993 307 311
28. Mellemkjaer L. Linet M.S. Gridley G. Frisch M. Moller H. Olsen J.H. Rheumatoid arthritis and cancer risk Eur J Cancer 32 1996 1753 1757
29. Prior P. Symmons D.P.M. Hawkins C.F. Scott D.L. Brown R. Cancer morbidity in rheumatoid arthritis Ann Rheum Dis 43 1984 128 131
30. Prior P. Cancer and rheumatoid arthritis: epidemiologic considerations Am J Med 78 1985 15 21
31. Katusic S. Beard M. Kurland L.T. Weis J.W. Bergstralh E. Occurrence of Malignant Neoplasms in the Rochester, Minnesota, Rheumatoid Arthritis Cohort Am J Med 78 1985 50 55
32. Moritomo H. Ueda T. Hiyama T. Hosono N. Mori S. Komatsubara Y. The Risk of Cancer in Rheumatoid Arthritis in Japan Scand J Rheumatol 24 1995 157 159
33. Cibere J. Sibley J. Haga M. Rheumatoid arthritis and the risk of malignancy Arthritis Rheum 40 1997 1580 1586
34. Tennis P. Andrews E. Bombardier C. Wang Y. Strand L. West R. Record linkage to conduct an epidemiology study on the association of rheumatoid arthritis and lymphoma in the province of Saskatchewan, Canada J Clin Epidemiol 46 1993 685 695
35. Kirsner A.B. Farber S.J. Sheon R.P. Finkel R.I. The incidence of malignant disease in patients receiving cytotoxic therapy for rheumatoid arthritis Ann Rheum Dis 41 1982 32 33
36. Kinlen L.J. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment Am J Med 78 1985 44 49
37. Matteson E.L. Hickey A.R. Maguire L. Tilson H.H. Urowitz M.B. Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in DMARD registry J Rheumatol 18 1991 809 814
38. Jones M. Symmons D.P.M. Finn J. Wolfe F. Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study Br J Rheumatol 35 1996 738 745
39. Hoover R. Fraumeni J.F. Risk of cancer in cancer in renal-transplant recipients Lancet ii 1973 55 57
40. Kinlen L.J. Sheil A.G.R. Peto J. Doll R. Collaborative United Kingdom-Australian study of cancer in patient treated with immunosuppressive agents Br Med J ii 1979 1461 1466
41. Bottomley W.W. Ford G. Cunliffe W.J. Cotterill J.A. Aggressive squamous cell carcinomas developing in patients receiving long-term azathioprine Br J Dermatol 133 1995 460 462
42. Pitt P.I. Sultan A.H. Malone M. Andrews V. Hamilton E.B.D. Association between azathioprine therapy and lymphoma in rheumatoid arthritis J R Soc Med 80 1987 428 429
43. Speerstra F. Boerbooms A.M. van de Putte L.B. van Beusekom H.J. Kruijsen M.W. Vandenbrouke J.P. Side-effects of azathioprine treatment in rheumatoid arthritis: analysis of 10 years of experience Ann Rheum Dis 41 1982 37 39
44. Silman A.J. Petrie J. Hazleman B. Evans S.J.W. Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study Ann Rheum Dis 47 1998 988 992
45. Pedersen-Bjergaard J. Eroboll J. Hansen V. Sorensen B.L. Christofferson K. Hou-Jensen K. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma N Engl J Med 318 1988 1028 1032
46. Tucker M. Meadows A. Boice J. Leukemia after therapy with alkylating agents for childhood cancer J Natl Cancer Inst 78 1987 455 464
47. Parsons J.L. Strong I.S. Fosdick W.N. The causes of death in patients with rheumatoid arthritis treated with cytotoxic agents J Rheumatol 1 1974 75
48. Pollock B.H. Barr J.H. Stroizer B.L. Elsenbeis Ch. Agarwal A. Marzolis H.M. Neoplasia and cyclophospharnide Arthritis Rheum 16 1973 524 545
49. Plotz P.H. Klippel J.H. Decker J.L. Grauman D. Wolff B. Brown B.C. Rutt G. Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis Ann Intern Med 91 1979 221 223
50. Ansher A.F. Melton J.W. III Sliwinski A.J. Bladder malignancy in a patient receiving low dose cyclophosphamide for treatment of rheumatoid arthritis Arthritis Rheum 26 1983 804 805
51. Baltus J.A.M. Boersma J.W. Hartman A.P. Vanderbroucke J.P. The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up Ann Rheum Dis 42 1983 368 373
52. Baker G.L. Kahl L.E. Zee B.C. Stolzer B.L. Agarwal A.K. Medsger T.A. Malignancy following treatment of rheumatoid arthritis with cyclophosphamide: Long-term case-control follow-up study Am J Med 83 1987 1 9
53. Radis C.D. Kahl L.E. Baker G.L. Chester M. Wasko M.C.M. Cash J.M. Effects of cyclosphosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis: a 20-year follow-up study Arthritis Rheum 38 1995 1120 1127
54. Abraham A.K. Phil A. Role of polyarnine in macromolecular synthesis Trends Biochem Sci 6 1981 1006 1007
55. Brody M. Bohm I. Baur R. Mechanisms of action of methotrexate: experimental evidence that methotrexate blocks the binding of interleukin 1 beta to the interleukin 1receptor on target cells Eur J Chem Clin Biochem 31 1993 667 674
56. Banerjee A. Benedict W.E. Production of sister chromatid exchanges by various cancer chemotherapeutic agents Cancer Res 39 1979 795 799
57. Benedict W.F. Banerjee A. Gardener A. Jones P.A. Induction of morphological transformations in mouse C3H/10Tl/2 clone 8 cells and chromosomal damage in hamster A(TI)CI-3 cells by cancer chemotherapeutic agents Cancer Res 37 1997 2202 2208
58. Sany J. Anaya J.M. Lussiez V. Couret M. Combe B. Daures J.P. Treatment of rheumatoid arthritis with methotrexate: a prospective open long-term study of 191 cases J Rheumatol 18 1991 1323 1327
59. Ellman M.H. Hurwitz H. Thomas C. Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate J Rheumatol 18 1991 1741 1743
60. Kingsmore S.F. Hall B.D. Allen N.B. Rice J.R. Caldwell D.S. Association of methotrexate, rheumatoid arthritis and lymphoma: report of two cases and literature review J Rheumatol 19 1992 1462 1465
61. Taillman B. Garnier G. Castanet J. Ferrarin E. Pesce A. Dujardin P. Lymphoma developing in a patient with rheumatoid arthritis taking methotrexate Clin Rheum 12 1993 93 94
62. Cobeta-Garcia J.C. Ruiz-Jimeno M.T. Fontova Gorrofe R. Non-Hodgkin's lymphoma, rheumatoid arthritis and methotrexate (letter) J Rheumatol 12 1993 1272 1273
63. Zimmer-Galler I. Lie J.T. Choroidal infiltrates as the initial manifestation of lymphoma in rheumatoid arthritis after treatment with low-dose methotrexate Mayo Clin Proc 69 1994 258 261.
64. Bologna C. Picot M.-C. Jorgensen C. Viu P. Verdier R. Sandy J. Study of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate Ann Rheum Dis 56 1997 97 102
65. Moder K.G. Tefferi A. Cohen M.D. Menke D.M. Luthra H.S. Hematologic Malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study Am J Med 99 1995 276 281
66. Bachman T.R. Sawitzke A.D. Perkins S.L. Ward J.H. Cannon G.W. Methotrexate-associated lymphoma in patients with rheumatoid arthritis Arthritis Rheum 39 1996 325 329
67. Kamel O.W. van de Rijn M. Weiss L.M. Del Zoppo G.L. Hench P.K. Robbins B.A. Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis N Engl J Med 328 1993 1317 1321
68. Viraben R. Brousse P. Lamant L. Reversible cutaneous lymphoma occurring during methotrexate Br J Dermatol 135 1996 116 118
69. Shiroky J.B. Frost A. Skelton J.D. Haegert D.G. Newkirk M.M. Neville C. Complications of immunosuppression associatedwith weekly low dose methotrexate J Rheumatol 18 1991 1172 1175
70. Thamason R.W. Craig F.E. Banks P.M. Sears D.L. Myerson G.E. Gulley M.L. Epstein-Baff virus and lymphoproliferation in methotrexate treated rheumatoid arthritis Mod Pathol 9 1996 261 266
71. van de Rijn M. Michael L.C. Variakojis D. Warnke R.A. Chang P.P. Kamel O.W. Epstein-Barr virus clonality in lymphomas occurring in patients with rheumatoid arthritis Arthritis Rheum 39 1996 638 642
72. Lioté F. Pertuiset E. Cochand-Priollet B. D'Agay M.F. Domlaret H. Numeric P. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis: role of Epstein-Barr virus infection J Rheumatol 22 1995 1174 1178
73. Usman A.R. Yunus M.B. Non-Hodgkin's lymphoma in patients with rheumatoid arthritis treated with low-dose methotrexate J Rheumatol 23 1996 1095 1097
74. Georgescu L. Quinn G.C. Schwartzman S. Paget S.A. Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment Sem Arthritis Rheum 27 1997 794 804
75. Kamel O.W. Weiss L.M. van de Rijn M. Colby T.V. Kingma D.W. Jaffe E.S. Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving longterm low-dose methotrexate therapy Am J Surg Pathol 20 1996 1279 1287
76. Jeannou J. Goupille P. Valat J.-P. Association of methotrexate, rheumatoid arthritis, and melanoma in 2 patients J Rheumatol 24 1997 1444 1445
77. Kerr L.D. Troy K. Isola L. Temporal association between the use of methotrexate and development of leukemia in 2 patients with rheumatoid arthritis J Rheumatol 22 1995 2356 2358
78. Weinblatt M.E. Maier A.L. Fraser P.A. Coblyn J.S. Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy J Rheumatol 25 1998 238 242
79. Kremer J.M. Safety, efficacy and mortality in a long-term cohort of patients with rheumatoid arthritis taking methotrexate: follow-up after a mean of 13.3 years Arthritis Rheum 40 1997 984 985
80. Szanto E. Low-dose methotrexate treatment of rheumatoid arthritis; long-term observation of efficacy and safety Clin Rheumatol 3 1989 323 330
81. Huang J.L. Methotrexate in the treatment of children with chronic arthritis-Long-term observations of efficacy and safety Br J Clin Pract 50 1996 311 314
82. Rose C.D. Singsen B.H. Eichenfield A.H. Goldsmith D.P. Athreya B.H. Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis J Pediatrics 4 1990 653 659
83. Blohme I. Brynger H. Malignant disease in renal transplant patients Transplantation 39 1985 23 35
84. Panayi G.S. Tugwell P. The use of cyclosporin A microemulsion in rheumatoid arthritis: conclusions of an international review Br J Rheumatol 36 1997 808 811
85. Lamarque V. Monka C. Commare M.C. Krupp P. Risk of malignancies in patients treated with Sandimmune for autoimmune disease Touraine J.L. Cancer in transplantation. Prevention and treatment 1996 Kluwer academic publishers Dordrecht 141 148
86. Arellano F. Krupp P. Malignancies in rheumatoid arthritis patients treated with cyclosporine A. Br J Rheumatol 32 1993 72 75
87. van den Borne B.E.E.M. Landewe R.B.M. Houkes I. Schild F. van der Heyden P.C.W. Hazes J.M.W. No increase risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis Arthritis Rheum 41 1998 1930 1937
88. rd ed. Textbook of Rheumatology 1989 WB Saunders Company Philadelphia, PA 804 823
89. Fries J.F. Bloch D. Spitz P. Mitchel D.M. Cancer in rheumatoid arthritis: a prospective long-term study of mortality Am J Med 78 1985 56 59
90. Bendix G. Bjelle A. Holmberg E. Cancer Morbidity in Rheumatoid Arthritis Patients Treated with Proresid- or Parenteral Gold Scand J Rheumatol 24 1995 79 84
91. McLaughlin J.R. Fields A.L.A. Gentleman J.F. Levy I. Whylie B. Whyttaker H. National Cancer Institute of Canada: Canadian Cancer Statistics 1997 1997
92. Kassan S.S. Thomas T.L. Moutsopoulos H.M. Hoover R. Kimberly R.P. Budman D.R. Increased risk of lymphoma in sicca syndrome Ann Intern Med 89 1978 888 892
93. Kauppi M. Pukkala E. Isomaki H. Elevated incidences of hematologic malignancies in patients with Sjogrens syndrome compared with patients with rheumatoid arthritis (Finland) Cancer Causes Control 8 1997 201 204
94. Porter D. Madhok R. Capell H. Non-Hodgkin's lymphoma in rheumatoid arthritis Ann Rheum Dis 50 1991 275 276
95. Depper J.M. Bluestein H.G. Zvaifler N.J. Impaired regulation of Epstein-Barr virus induced lymphocyte proliferation in rheumatoid arthritis due to a T cell defect J Immunol 127 1981 1899 1902
96. Tosato G. Steinberg A.D. Yarchoan R. Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis J Clin Invest 73 1984 1789 1795
97. Kahan A. Kahan A. Amor B. Menkes C.J. Different defects of T cell regulation of Epstein-Barr virus-induced B cell activation in rheumatoid arthritis Arthritis Rheum 28 1985 961 970
98. Kuryliszin-Moskal A. Comparison of blood and synovial fluid lymphocytes subsets in rheumatoid arthritis and osteoarthritis Clin Rheumatol 14 1995 43 50
99. Connell W.R. Kamm M.A. Dickson M. Balkwill A.M. Richie J.K. Lennard-Jones J.E. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease Lancet 343 1994 1249 1252
100. Congavreaux C. Saddier P. Grimaud J. Moreau Th. Adeleine P. Aimard G. Risk of cancer from azathioprine therapy in multiple sclerosis: A case-control study Neurology 46 1996 1607 1611
101. Dantal J. Hourmant M. Cantarovich D. Giral M. Blancho G. Dreno B. Soulillou J.-P. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporine regimens Lancet 351 1998 623 628
102. Nyfors A. Jensen H. Frequency of malignant Neoplasms in 248 long-term methotrexate-treated psoriatics Dermatologica 167 1983 260 261
103. Stern R.S. Zierler S. Parrish J.A. Methotrexate used for psoriasis and the risk of noncutaneous or cutaneous malignancy Cancer 50 1982 869 872